Print

Featured Studies Results

Comparing Shorter vs. Standard Radiation for High-Risk Prostate Cancer (High Five)

https://www.facingourrisk.org/research-clinical-trials/study/397 /comparing-shorter-vs-standard-radiation-for-high-risk-prostate-cancer

Clinicaltrials.gov identifier:
NCT05946213 (https://clinicaltrials.gov/show/NCT05946213)

Treatment
Phase 3 treatment study for high-risk prostate cancer

Have You Had A Genetic Counseling Visit For Personal Or Family History Of Cancer?

https://www.facingourrisk.org/research-clinical-trials/study/422 /have-you-had-a-genetic-counseling-visit-for-personal-or-family-history-of-cancer

Surveys, Registries, Interviews
Survey for racially diverse people about their genetic counseling experience

Testing the Drug CX-5461 for Treating Metastatic Solid Tumors

https://www.facingourrisk.org/research-clinical-trials/study/431 /testing-the-drug-cx-5461-for-treating-metastatic-solid-tumors

Clinicaltrials.gov identifier:
NCT06606990 (https://clinicaltrials.gov/show/NCT06606990)

Treatment
Phase 1 study for treatment of advanced solid tumors

Using the Drug Daraxonrasib in Surgically Removed Pancreatic Cancer (RASolute 304)

https://www.facingourrisk.org/research-clinical-trials/study/389 /using-the-drug-daraxonrasib-in-surgically-removed-pancreatic-cancer-rasolute-304

Clinicaltrials.gov identifier:
NCT07252232 (https://clinicaltrials.gov/show/NCT07252232)

Treatment
Phase 3 study for pancreatic cancer treatment after surgery and chemotherapy

Testing a New Targeted Therapy ETX-19477 to Treat Advanced Breast, Colorectal Endometrial, Ovarian or Pancreatic Cancer in People with a BRCA2 Mutation (ERADIC8)

https://www.facingourrisk.org/research-clinical-trials/study/432 /testing-a-new-targeted-therapy-etx-19477-to-treat-advanced-solid-tumors-eradic8

Clinicaltrials.gov identifier:
NCT06395519 (https://clinicaltrials.gov/show/NCT06395519)

Treatment
Phase 1/2 treatment study for people with advanced breast, colorectal, endometrial, ovarian or pancreatic cancer

Evaluating the Safety of Nipple Sparing Mastectomy in Women With a High Risk for Breast Cancer

https://www.facingourrisk.org/research-clinical-trials/study/392 /evaluating-the-safety-of-nipple-sparing-mastectomy-in-women-with-a-high-risk-for-breast-cancer

Clinicaltrials.gov identifier:
NCT06888388 (https://clinicaltrials.gov/show/NCT06888388)

Prevention
Study for people considering double mastectomy to reduce breast cancer risk

Using a Mobile Health App to Improve Quality of Life in Black Men with Prostate Cancer

https://www.facingourrisk.org/research-clinical-trials/study/411 /using-a-mobile-health-app-to-improve-quality-of-life-in-black-men-with-prostate-cancer

Clinicaltrials.gov identifier:
NCT06651359 (https://clinicaltrials.gov/show/NCT06651359)

Quality of Life
Quality of life study for Black men with prostate cancer

Study of a New Oral Medication, Daraxonrasib After Surgery to Help Prevent Pancreatic Cancer from Returning

https://www.facingourrisk.org/research-clinical-trials/study/378 /study-of-a-new-oral-medication-daraxonrasib-after-surgery-to-help-prevent-pancreatic-cancer-from-returning

Clinicaltrials.gov identifier:
NCT07252232 (https://clinicaltrials.gov/show/NCT07252232)

Treatment
Phase 3 treatment trial for pancreatic cancer that was removed by surgery

ENGAGE: Surveys to Assess Decision-Making on Genetic Counseling and Testing for Lynch Syndrome

https://www.facingourrisk.org/research-clinical-trials/study/416 /engage-surveys-to-assess-decision-making-on-genetic-counseling-and-testing-for-lynch-syndrome

Clinicaltrials.gov identifier:
NCT07106359 (https://clinicaltrials.gov/show/NCT07106359)

Surveys, Registries, Interviews
Clinical trial for untested individuals at risk for Lynch syndrome

Share Your Child's Genetic Diagnostic Journey

https://www.facingourrisk.org/research-clinical-trials/study/417 /share-your-childs-genetic-diagnostic-journey

Surveys, Registries, Interviews
Interview with Latino/a parents about their child's genetic care

Experiences with Genetic Counseling Among Individuals with a BRCA1 or BRCA2 Genetic Mutation

https://www.facingourrisk.org/research-clinical-trials/study/415 /experiences-with-genetic-counseling-among-individuals-with-a-brca1-or-brca2-genetic-mutation

Surveys, Registries, Interviews
Survey for people with a positive BRCA1 and/or BRCA2 mutation.

Comparing Two Vaccine Treatments With Immunotherapy for Pancreatic Cancer Before and After Surgery

https://www.facingourrisk.org/research-clinical-trials/study/386 /comparing-two-vaccine-treatments-with-immunotherapy-for-pancreatic-cancer-before-and-after-surgery

Clinicaltrials.gov identifier:
NCT06782932 (https://clinicaltrials.gov/show/NCT06782932)

Treatment
Phase 1b/2 treatment study for newly diagnosed pancreatic cancer that can be removed with surgery and who have not yet received treatment

Health and Medicine Decision-Making Study

https://www.facingourrisk.org/research-clinical-trials/study/382 /health-and-medicine-decision-making-study

Surveys, Registries, Interviews
Study for people diagnosed with a complex health condition such as cancer, diabetes or an autoimmune disorder

Studying the Impact of Cancer-Related Financial Challenges on Couples’ Health

https://www.facingourrisk.org/research-clinical-trials/study/399 /studying-the-impact-of-cancer-related-financial-challenges-on-couples-health

Surveys, Registries, Interviews
Survey for people who are receiving or have received cancer treatment and their partner

Vaccine for People at High Risk for Pancreatic Cancer

https://www.facingourrisk.org/research-clinical-trials/study/365 /vaccine-for-those-at-high-risk-of-developing-pancreatic-cancer

Clinicaltrials.gov identifier:
NCT05013216 (https://clinicaltrials.gov/show/NCT05013216)

Prevention
Phase 1 pancreatic cancer prevention study for people at high risk

Comparing an Investigational Targeted Drug AZD5335 to Standard Treatments in People With Platinum‑Resistant Ovarian Cancer (TREVI‑OC‑01)

https://www.facingourrisk.org/research-clinical-trials/study/371 /comparing-an-investigational-targeted-drug-azd5335-to-standard-treatments-in-people-with-platinumresistant-ovarian-cancer-trevioc01

Clinicaltrials.gov identifier:
NCT07218809 (https://clinicaltrials.gov/show/NCT07218809)

Treatment
Phase 3 treatment study for platinum-resistant ovarian cancer

Using a Blood Test to Detect Early Cancer Recurrence After Treatment (ORACLE)

https://www.facingourrisk.org/research-clinical-trials/study/372 /using-a-blood-test-to-detect-early-cancer-recurrence-after-treatment-oracle

Clinicaltrials.gov identifier:
NCT05059444 (https://clinicaltrials.gov/show/NCT05059444)

Treatment
Post-treatment study to monitor for recurrence

A Study for Women Having Revision Breast Implant Surgery

https://www.facingourrisk.org/research-clinical-trials/study/402 /a-study-for-women-having-revision-breast-implant-surgery

Clinicaltrials.gov identifier:
NCT05945329 (https://clinicaltrials.gov/show/NCT05945329)

Prevention
An interventional study for women undergoing revision breast implant surgery

About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.